Insider Selling: Renalytix (LON:RENX) Insider Sells £70,000.02 in Stock

Renalytix Plc (LON:RENX - Get Free Report) insider Christopher Mills sold 1,166,667 shares of the stock in a transaction that occurred on Tuesday, September 29th. The shares were sold at an average price of GBX 6, for a total transaction of £70,000.02.

Renalytix Trading Down 4.8%

RENX stock opened at GBX 5.81 on Friday. The company has a market capitalization of £25.38 million, a PE ratio of -1.45 and a beta of 1.81. The company has a debt-to-equity ratio of -483.33, a quick ratio of 2.42 and a current ratio of 1.57. Renalytix Plc has a one year low of GBX 1.60 and a one year high of GBX 10. The company's 50 day moving average price is GBX 4.54 and its two-hundred day moving average price is GBX 2.95.

About Renalytix

(Get Free Report)

Renalytix (LSE: RENX) (NASDAQ: RNLX) is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally. The Company's lead product is KidneyIntelX, which has been granted Breakthrough Designation by the U.S. Food and Drug Administration and which is being designed to help make significant improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery (visit www.kidneyintelx.com).

Recommended Stories

• Five stocks we like better than Renalytix
• Everyone in AI Is Quietly Copying Palantir's Playbook
• Advanced Micro Devices Is Spending $8.2 Billion to Learn What AI Needs Next
• JPMorgan Bets on Genius Sports as the Market Loses Patience
• Apple’s $5.7 Billion Patent Verdict Raises a Bigger Royalty Question

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].